Israel Chemicals Ltd (NYSE:ICL) hit a new 52-week low during trading on Wednesday . The company traded as low as $4.91 and last traded at $4.91, with a volume of 134456 shares trading hands. The stock had previously closed at $5.39.
A number of research analysts recently commented on ICL shares. ValuEngine lowered Israel Chemicals from a “buy” rating to a “hold” rating in a research note on Saturday, June 1st. Zacks Investment Research upgraded Israel Chemicals from a “hold” rating to a “strong-buy” rating and set a $6.00 target price for the company in a research note on Friday, June 7th. Three investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $5.94.
The firm’s 50 day simple moving average is $5.22. The company has a quick ratio of 0.85, a current ratio of 1.51 and a debt-to-equity ratio of 0.53. The stock has a market cap of $6.77 billion, a price-to-earnings ratio of 13.30, a price-to-earnings-growth ratio of 1.35 and a beta of 0.83.
Israel Chemicals (NYSE:ICL) last released its quarterly earnings data on Wednesday, July 31st. The basic materials company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.01. Israel Chemicals had a return on equity of 14.03% and a net margin of 9.04%. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same period in the prior year, the company posted $0.09 earnings per share. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. As a group, equities research analysts expect that Israel Chemicals Ltd will post 0.42 earnings per share for the current fiscal year.
A number of institutional investors have recently added to or reduced their stakes in the business. Signaturefd LLC raised its stake in Israel Chemicals by 30.1% during the second quarter. Signaturefd LLC now owns 13,119 shares of the basic materials company’s stock worth $68,000 after acquiring an additional 3,038 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Israel Chemicals by 2.6% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 170,427 shares of the basic materials company’s stock worth $887,000 after acquiring an additional 4,322 shares in the last quarter. Ballentine Partners LLC raised its stake in Israel Chemicals by 20.5% during the second quarter. Ballentine Partners LLC now owns 26,747 shares of the basic materials company’s stock worth $139,000 after acquiring an additional 4,546 shares in the last quarter. Parametric Portfolio Associates LLC raised its stake in Israel Chemicals by 0.3% during the first quarter. Parametric Portfolio Associates LLC now owns 1,840,795 shares of the basic materials company’s stock worth $9,646,000 after acquiring an additional 4,739 shares in the last quarter. Finally, Wetherby Asset Management Inc. raised its stake in Israel Chemicals by 49.9% during the second quarter. Wetherby Asset Management Inc. now owns 18,566 shares of the basic materials company’s stock worth $97,000 after acquiring an additional 6,182 shares in the last quarter. Hedge funds and other institutional investors own 7.90% of the company’s stock.
Israel Chemicals Company Profile (NYSE:ICL)
Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.
Read More: What is Cost of Debt?
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.